Form 10-Q · Quarterly report
Marsh McLennan 10-Q, filed Jul 21, 2026
- Filed
- CIK
- 0000062709
- Accession no.
- 0000062709-26-000195
Summary
Marsh reported second-quarter 2026 consolidated revenue of $7.4 billion, up 6%, and diluted earnings per share of $2.63, up 7%, while first-half operating income fell 5% partly because of a $425 million estimated liability and legal expenses related to Greensill litigation. The company also changed its brand name to Marsh, renaming its Marsh and Oliver Wyman Group businesses as Marsh Risk and Marsh Management Consulting.
Key points
- Marsh reported second-quarter 2026 revenue rose 6% to $7.4 billion, with diluted earnings per share up 7% to $2.63.
- Marsh recorded a $425 million estimated liability and legal expenses in the first quarter of 2026 related to Greensill litigation, contributing to a 5% decline in first-half operating income.
- Marsh completed five acquisitions in 2026 for $181 million and repurchased 8.7 million shares for $1.5 billion in the first half of 2026.
- In June 2026, Marsh replaced its $3.5 billion five-year revolving credit facility with a $4.25 billion facility expiring in June 2031.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. References in this report are to Marsh & McLennan Companies, Inc. and its consolidated subsidiaries (the "Company" or "Marsh"), unless the context otherwise requires. Effective January 14, 2026, the Company updated its brand name from Marsh McLennan to Marsh and the brand names of Marsh and Oliver Wyman Group businesses to Marsh Risk and Marsh Management Consulting, respectively. References to the Company and its businesses in this report reflect these changes. Mercer and Guy Carpenter will continue to report under their current brands through a transition period. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.